INTRODUCTION
The first medicated chewing gum was introduced in the USA in 1924 with the brand name Aspergum® (Imfeld, 1999) . But history suggests that chewing of non-food items for the purpose of pleasure is as old as ancient Egyptian, Mayan civilizations. In 1848, the first commercial chewing gum named State of Maine Pure Spruce Gum appeared in the market whereas the first patent was issued to Dr. W.F. Semple who was a dentist at Ohio in 1869. Many people chew gum partly due to the belief that it increases aspects of mental performance, including concentration (Wilkinson et al., 2002) . In a study published by Al-Haboubi et al. in 2010 concluded that regular use of sugar-free chewing gum is associated with certain clinical and self-perceived benefits in older people living in the community. Scholey et al. 2009 found that the chewing of gum was associated with a small overall increase in performance on a battery of cognitive tests. Other studies indicate that chewing gum offers a range of benefits (Onyper et al., 2011) like verbal working memory (Hirano et al., 2008; Zoladz and Raudenbush, 2005) , free recall (Baker et al., 2004; Johnson & Miles, 2008) , attention (Smith, 2010; Tucha et al., 2004; Tucha & Simpson, 2011) , as well as performance on reaction time measures (Sakamotoet et al., 2009; Smith, 2010) .
As chewing gums are taken orally and oral route of drug delivery is the most preferred route amongst the patient and clinicians due to various advantages it offers (Shojaei, 1998) , in recent years chewing gums are considered to be friendly oral mucosal drug delivery systems (Surana, 2010) . Chewing gum has been used to deliver therapeutic agents such as nicotine for smoking cessation therapy (Batra et al., 2005; Moore et al., 2008) . A medicated chewing gum is solid, single-dose preparation that is intended to be chewed for a certain period of time, deliver the drug and which may contain one or more than one active pharmaceutical ingredient (Mehta et al., 2010) . Chewing gums are not swallowed and the remaining mass after chewing is discarded. During chewing the drug contained in the gum is released into the saliva. The released drug has got two fates; either it could be absorbed through the oral mucosa or may reach the stomach for GI absorption. In fact both these two fates may occur simultaneously. So, medicated chewing gums offer both local and systemic effect. This drug delivery system offers two 
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BENEFITS
Medicated chewing gums offer a range of advantages as identified by the classic review work of Imfeld in 1999. The advantages may be summarized as bellow:  Chewing gum can be used without water, at any time, and everywhere.  As the incorporated therapeutic agents are protected from oxygen, light, and water, product stability is good.  Chewing gum can produce both local effects in the mouth (local delivery) and systemic effects after the active agents have been swallowed or (preferably) after they have been absorbed through the oral mucosa. The later is of special interest with respect to bioavailability, since it avoids metabolism of the drug in the gastrointestinal tract and the so called liver-first-pass effect, because oral veins drain into the vena cava.
The other benefits that chewing gum may offer as a pharmaceutical dosage form are (Rassing, 1996; Surana, 2010; Heema and Stuti, 2010 
MANUFACTURING AND EVALUATION
Medicated chewing gums can be manufactured by various techniques and methods. There are three major manufacturing methods available for medicated chewing gum formulation; 1) Conventional/ traditional method (melting) (Athanikar and Gubler, 2001) , 2) freezing, grinding and tabletting method (Athanikar and Gubler, 2001; Keizo and Fumio, 1976 ) and 3) direct compression method (Heema and Stuti, 2010) . Chewing gum prepared by using directly compressible chewing gum excipients like PharmaGum S, M and C offers formulation of a chewing gum which delivers drug more quickly and can be prepared in a more cost effective manner. The other two methods have got some limitations as described in Table 1 . 
BENEFITS MANUFACTURING AND EVALUATION Composition
The most important material in chewing gum formulation apart from the active ingredient is the gum base which is an inert and insoluble no-nutritive component. The other materials may be grouped as water soluble bulk portion (Zyck et al., 2003) . Table 2 summarizes the basic components required for the manufacturing of medicated chewing gum with (Bhise and Jahagirdar, 2005; Heema and Stuti, 2010) .
Evaluation
Product quality tests for medicated chewing gums are described by Gajendran et al. (2008) according to European Pharmacopoeia. The tests include assay, identification and uniformity of dosage units, content, and mass. In addition to product quality tests several additional tests are done which are specific to the product and these tests ensure that the finished product is of quality as desired by the manufacturer. The tests generally include: texture analysis, product feel and consistency, evaluation of flavors and sweeteners, tests for coatings, impurities, water content, degradation products, residual solvents, etc. As USP does not contain a compendial apparatus for performance testing of medicated chewing gums in many cases product performance data are generated by apparatus developed by the drug product manufacturers and is not contained in the public monograph. European Pharmacopoeia, 2000) . Apparatus II, Alternative Chewing Gum Apparatus, Noncompendial-Wennergren is one of the noncompendial apparatus commercially available which was designed by Wennergren (Kvist et al., 1999) . Schematic diagram of apparatus for determination of drug release and single-module chewing apparatus (apparatus II) for in vitro drug releases study of medicated chewing gum are presented in Figure 1 and Figure 2 respectively.
THERAPEUTIC APPLICATION
Medicated chewing gums are used in various therapeutic purposes. A brief list of the therapeutic uses of medicated chewing gums is given in Table 3 .
CONCLUSION
Medicated chewing gums could be a great way of delivering drug to the body either for local or systemic effect. The preparation procedure is easy and the dosage form is convenient to use, has got great 
Therapeutic use Specific example Reference
Oral antifungal Econazole Nystatine Miconazole Jacobsen et al., 1999 Andersen et al., 1990 Pedersen and Rassing, 1990a Jacobsen et al., 1999; Pedersen and Rassing, 1990b; Pedersen and Rassing, 1991; Rindum et al., 1993; Bastian et al., 2004 Smoking cessation Nicotine Silver acetate Jensen et al., 1990; Jensen et al., 1991; Peters and Morgan, 2002; Morjaria et al., 2004 Malcolm et al., 1986 Jensen et al., 1990; Jensen et al., 1991 Pain relievers Aspirin Methadone Bousquet et al., 1992; Rassing, 1988 Hodoba, 1999 CNS 
